Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

GoodRx

Biotech & Life Sciences · Santa Monica, United States · Founded 2011 · IPO 2020 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.08B
Market cap · May/2026
Revenue
$797M
Latest reported FY
EBITDA
$236M
Latest reported FY

Provides health consumers with convenient and affordable prescription drugs

Investors

12 investors on GoodRx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Global footprint

Where GoodRx has talent and traffic

AI talent share
3.0% of workforce is AI talent
(33 of 1,093 staff)
Core AI50.46%
Other AI282.56%
Non-AI workforce1,06096.98%
Workforce by country
20 countries with
team presence
🇺🇸 United States95.7%
🇮🇳 India0.8%
🇧🇷 Brazil0.8%
🇵🇱 Poland0.2%
🇫🇷 France0.1%
Top 5 of 20 shown
Web traffic by country
21M monthly visits
across markets
🇺🇸 United States84.9%
🇨🇦 Canada3.4%
🇦🇺 Australia1.8%
🇮🇳 India1.8%
🇵🇭 Philippines0.7%
Top 5 markets shown

Patent intelligence

$340k patent portfolio · 3 active families

Estimated portfolio value
$340k
0.03% of market cap · 1.8× smaller than top peer Omada Health ($612k)
3 active patent families
Where GoodRx innovates DatabaseDrug productPharmacyDrug pricesIdentifying medications

Where GoodRx concentrates vs peers

Each axis is a top-10 topic across GoodRx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

GoodRx's 7 investments and acquisitions.

Every disclosed deal where GoodRx appeared as a backer or acquirer, 2012–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across GoodRx's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        GoodRx's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Sentiment on X

        What X is saying about GoodRx

        An AI-synthesized read of the highest-engagement posts about GoodRx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See GoodRx on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.